Home LiteratureArticle Details
PMID: 26502405 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma.

Nature immunology ·Vol. 16 ·No. 12 ·2015-12-00 ·Pages 1235-44

Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, Browning JL, Goossens N, Nakagawa S, Gunasekaran G, Schwartz ME, Kobayashi M, Kumada H, Berger M, Pappo O, Rajewsky K, Hoshida Y, Karin M, Heikenwalder M, Ben-Neriah Y, Pikarsky E

Abstract

Ectopic lymphoid-like structures (ELSs) are often observed in cancer, yet their function is obscure. Although ELSs signify good prognosis in certain malignancies, we found that hepatic ELSs indicated poor prognosis for hepatocellular carcinoma (HCC). We studied an HCC mouse model that displayed abundant ELSs and found that they constituted immunopathological microniches wherein malignant hepatocyte progenitor cells appeared and thrived in a complex cellular and cytokine milieu until gaining self-sufficiency. The egress of progenitor cells and tumor formation were associated with the autocrine production of cytokines previously provided by the niche. ELSs developed via cooperation between the innate immune system and adaptive immune system, an event facilitated by activation of the transcription factor NF-κB and abolished by depletion of T cells. Such aberrant immunological foci might represent new targets for cancer therapy.

MeSH Terms
Adaptive Immunity/genetics,immunology Animals Carcinoma, Hepatocellular/genetics,immunology,metabolism Comparative Genomic Hybridization Cytokines/genetics,immunology,metabolism Disease Models, Animal Hepatocytes/immunology,metabolism,pathology Humans I-kappa B Kinase/genetics,immunology,metabolism Immunity, Innate/genetics,immunology Immunoblotting In Situ Hybridization Liver Neoplasms/genetics,immunology,metabolism Lymphoid Tissue/immunology,metabolism,pathology Mice, Inbred C57BL Mice, Knockout Mice, Transgenic NF-kappa B/genetics,immunology,metabolism Neoplastic Stem Cells/immunology,metabolism Reverse Transcriptase Polymerase Chain Reaction Stem Cell Niche/genetics,immunology T-Lymphocytes/immunology,metabolism Transcriptome/genetics,immunology
Chemicals
Cytokines NF-kappa B I-kappa B Kinase
Authors & Affiliations
21 authors, click to expand affiliations / ORCID
Finkin Shlomi
Department of Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel. | Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Yuan Detian
Institute of Virology, Technische Universität München, Helmholtz Zentrum München, Munich, Germany.
Stein Ilan
Department of Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel. | Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Taniguchi Koji
Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, School of Medicine, University of California, San Diego, La Jolla, California, USA.
Weber Achim
Institute of Surgical Pathology, University and University-Hospital Zurich, Zurich, Switzerland.
Unger Kristian
Research Unit of Radiation Cytogenetics, Helmholtz-Zentrum München, Ingolstädter-Landstrasse, Neuherberg, Germany.
Browning Jeffrey L
Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.
Goossens Nicolas
Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. | Division of Gastroenterology &Hepatology Geneva University Hospital, Geneva, Switzerland.
Nakagawa Shigeki
Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Gunasekaran Ganesh
Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Schwartz Myron E
Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Kobayashi Masahiro
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
Kumada Hiromitsu
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
Berger Michael ORCID
Department of Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Pappo Orit
Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Rajewsky Klaus
Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Hoshida Yujin ORCID
Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Karin Michael
Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, School of Medicine, University of California, San Diego, La Jolla, California, USA.
Heikenwalder Mathias
Institute of Virology, Technische Universität München, Helmholtz Zentrum München, Munich, Germany. | Division of Chronic Inflammation and Cancer, German Cancer Research Center, Heidelberg, Germany.
Ben-Neriah Yinon
Department of Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Pikarsky Eli
Department of Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel. | Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
References (48)
48 references, click to expand
  1. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.
    J Clin Oncol. 2008 Sep 20;26(27):4410-7 PMID: 18802153
  2. The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study.
    Hepatology. 1993 Mar;17(3):366-71 PMID: 8444410
  3. Management of hepatocellular carcinoma: an update.
    Hepatology. 2011 Mar;53(3):1020-2 PMID: 21374666
  4. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
    Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 PMID: 16199517
  5. Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice.
    J Pathol. 2009 Feb;217(3):353-61 PMID: 19090486
  6. A lymphotoxin-driven pathway to hepatocellular carcinoma.
    Cancer Cell. 2009 Oct 6;16(4):295-308 PMID: 19800575
  7. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice.
    Nat Biotechnol. 2001 Aug;19(8):746-50 PMID: 11479567
  8. CGHregions: dimension reduction for array CGH data with minimal information loss.
    Cancer Inform. 2007 Feb 08;3:55-63 PMID: 19455235
  9. T cell-derived lymphotoxin regulates liver regeneration.
    Gastroenterology. 2009 Feb;136(2):694-704.e4 PMID: 18952083
  10. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
    Gut. 2012 Dec;61(12):1733-43 PMID: 22267597
  11. Gene expression in fixed tissues and outcome in hepatocellular carcinoma.
    N Engl J Med. 2008 Nov 6;359(19):1995-2004 PMID: 18923165
  12. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.
    Cell. 2013 Oct 10;155(2):384-96 PMID: 24120137
  13. Divergent gene regulation and growth effects by NF-kappa B in epithelial and mesenchymal cells of human skin.
    Oncogene. 2003 Apr 3;22(13):1955-64 PMID: 12673201
  14. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number.
    Anal Chem. 2011 Nov 15;83(22):8604-10 PMID: 22035192
  15. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation.
    Science. 1999 Apr 9;284(5412):309-13 PMID: 10195894
  16. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer.
    Cell. 2006 Feb 24;124(4):823-35 PMID: 16497591
  17. The pathology of hepatitis C.
    Hepatology. 1992 Apr;15(4):567-71 PMID: 1551631
  18. Tertiary lymphoid tissue: A gateway for T cells in the tumor microenvironment.
    Oncoimmunology. 2014 May 15;3:e28850 PMID: 25083321
  19. A faster circular binary segmentation algorithm for the analysis of array CGH data.
    Bioinformatics. 2007 Mar 15;23(6):657-63 PMID: 17234643
  20. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling.
    Am J Pathol. 2011 Jul;179(1):37-45 PMID: 21703392
  21. Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers.
    Clin Cancer Res. 2014 Apr 15;20(8):2147-58 PMID: 24523438
  22. Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.
    Hepatology. 1999 Jul;30(1):143-50 PMID: 10385650
  23. CGHcall: calling aberrations for array CGH tumor profiles.
    Bioinformatics. 2007 Apr 1;23(7):892-4 PMID: 17267432
  24. Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer.
    Cancer Cell. 2008 Dec 9;14(6):471-84 PMID: 19061838
  25. Tumor necrosis factor, lymphotoxin and cancer.
    IUBMB Life. 2010 Apr;62(4):283-9 PMID: 20155809
  26. Molecular profiling to predict hepatocellular carcinoma outcome.
    Expert Rev Gastroenterol Hepatol. 2009 Apr;3(2):101-3 PMID: 19351279
  27. Hepatic expression of HCV RNA-dependent RNA polymerase triggers innate immune signaling and cytokine production.
    Mol Cell. 2012 Oct 26;48(2):313-21 PMID: 22959272
  28. Ectopic lymphoid-like structures in infection, cancer and autoimmunity.
    Nat Rev Immunol. 2014 Jul;14(7):447-62 PMID: 24948366
  29. Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation.
    Immunity. 2006 Jun;24(6):729-39 PMID: 16782029
  30. Spatiotemporal basis of innate and adaptive immunity in secondary lymphoid tissue.
    Annu Rev Cell Dev Biol. 2014;30:141-67 PMID: 25150013
  31. Identification of direct genomic targets downstream of the nuclear factor-kappaB transcription factor mediating tumor necrosis factor signaling.
    J Biol Chem. 2005 Apr 29;280(17):17435-48 PMID: 15722553
  32. NF-kappaB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival.
    Cancer Lett. 2002 Oct 8;184(1):97-104 PMID: 12104053
  33. Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection.
    Nat Immunol. 2013 Jun;14(6):574-83 PMID: 23584070
  34. Lymphotoxin's link to carcinogenesis: friend or foe? from lymphoid neogenesis to hepatocellular carcinoma and prostate cancer.
    Adv Exp Med Biol. 2011;691:231-49 PMID: 21153327
  35. CD4⁺ follicular helper T cell infiltration predicts breast cancer survival.
    J Clin Invest. 2013 Jul;123(7):2873-92 PMID: 23778140
  36. N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation.
    Pharmacol Ther. 1996;71(1-2):57-81 PMID: 8910949
  37. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.
    Hepatology. 1998 Feb;27(2):407-14 PMID: 9462638
  38. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.
    Nat Rev Cancer. 2013 Feb;13(2):123-35 PMID: 23344543
  39. Lymphotoxin, NF-ĸB, and cancer: the dark side of cytokines.
    Dig Dis. 2012;30(5):453-68 PMID: 23108301
  40. Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition.
    Cell Metab. 2014 Jul 1;20(1):133-44 PMID: 24910242
  41. Hepatocellular carcinoma.
    N Engl J Med. 2011 Sep 22;365(12):1118-27 PMID: 21992124
  42. NF-kappaB functions as a tumour promoter in inflammation-associated cancer.
    Nature. 2004 Sep 23;431(7007):461-6 PMID: 15329734
  43. Lymphoid organ development: from ontogeny to neogenesis.
    Nat Immunol. 2006 Apr;7(4):344-53 PMID: 16550197
  44. DNA excision in liver by an albumin-Cre transgene occurs progressively with age.
    Genesis. 2000 Feb;26(2):149-50 PMID: 10686614
  45. 12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?
    Sci Rep. 2012;2:765 PMID: 23097687
  46. Regulation of adaptive immunity by the innate immune system.
    Science. 2010 Jan 15;327(5963):291-5 PMID: 20075244
  47. Evolution of inflammatory diseases.
    Curr Biol. 2012 Sep 11;22(17):R733-40 PMID: 22975004
  48. Histopathology of HCV infection.
    Clin Liver Dis. 1997 Nov;1(3):529-41, vi PMID: 15560056
Article Info
Journal
Nature immunology
Abbr.
Nat Immunol
ISSN
1529-2916
Published
2015-12-00
Epub
2015-00-26
Pages
1235-44
Language
English
Region
United States
NLM ID
100941354
PMCID
PMC4653079
Subset
IM
Grants
NCI NIH HHS · CA118165 · United States
Worldwide Cancer Research · 05-0121 · United Kingdom
NIEHS NIH HHS · P42 ES010337 · United States
NIDDK NIH HHS · DK099558 · United States
NIEHS NIH HHS · ES010337 · United States
NCI NIH HHS · R01 CA118165 · United States
NIAID NIH HHS · R01 AI043477 · United States
NIDDK NIH HHS · R01 DK099558 · United States
NIAID NIH HHS · AI0043477 · United States
NCI NIH HHS · P30 CA196521 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com